Understanding the Nuchal Translucency Test
The nuchal translucency measurement is obtained during an ultrasound examination in the first trimester, typically between 11 and 14 weeks of gestation. The measurement represents the depth of a fluid collection beneath the skin at the posterior neck of the fetus.
During the scan, a sonographer will:
- Measure the NT thickness and compare it against age-specific reference ranges
- Determine the crown-rump length (CRL), the distance from the top of the head to the base of the buttocks
- Estimate gestational age based on fetal anatomy
- Screen for other structural or anatomical markers
NT screening does not diagnose genetic disorders—it identifies pregnancies at higher statistical risk. Interpretation requires integration with maternal age, blood chemistry results, and family history for comprehensive risk assessment.
Calculating Expected Nuchal Translucency
The expected NT thickness for a given fetal size follows a linear relationship with crown-rump length. The formula below predicts the typical NT value; actual measurements are then plotted against population percentiles to determine whether the result falls within normal limits.
Expected NT (mm) = 0.437 + (0.01969 × CRL)
Gestational age (days) = round(8.052 × √(CRL × 1.037) + 23.73)
NT— Nuchal translucency thickness, measured in millimetersCRL— Crown-rump length of the fetus, measured in millimetersGestational age— Age of the pregnancy estimated from fetal biometry, expressed in days
Chromosomal Abnormalities and Elevated Nuchal Translucency
An increased NT thickness is associated with higher risk of several genetic conditions:
- Down syndrome (Trisomy 21): The most common chromosomal abnormality compatible with life. Infants often have characteristic facial features, congenital heart defects, and intellectual disability ranging from mild to moderate.
- Edwards syndrome (Trisomy 18): A severe condition with multiple organ involvement. Most affected infants do not survive beyond the first year of life.
- Patau syndrome (Trisomy 13): Characterized by severe developmental abnormalities. Survival beyond infancy is uncommon.
- Congenital heart defects: Even without chromosomal abnormalities, elevated NT can indicate structural cardiac malformations requiring postnatal intervention.
Measurements below the 95th percentile are considered within normal limits. Risk increases substantially above this threshold, particularly when NT exceeds 3.5 mm.
Important Considerations for NT Interpretation
Several factors influence how NT results should be understood and acted upon:
- Normal NT does not exclude genetic disorders — A normal NT measurement significantly reduces but does not eliminate the risk of chromosomal abnormalities. Additional screening methods—including maternal serum biomarkers (PAPP-A, beta-hCG), cell-free fetal DNA testing, and detailed anatomical survey—provide complementary risk stratification.
- Timing matters for accurate measurement — NT screening is valid only between 11 weeks 2 days and 14 weeks 1 day of gestation. Measurements obtained outside this window may not be reliably compared to published reference ranges, potentially leading to misinterpretation.
- Technical quality affects reliability — Obtaining an accurate NT measurement requires proper fetal positioning, image orientation, and operator expertise. Poor image quality or inadequate measurement technique can produce falsely elevated or low values that do not reflect true risk.
- Maternal age influences overall risk — Older maternal age increases the baseline risk of chromosomal abnormalities independent of NT thickness. A 35-year-old with identical NT to a 25-year-old faces higher overall risk due to age-related increases in aneuploidy.
Interpreting Results: Risk Stratification
The NT percentile determines how your measurement compares to other fetuses of the same crown-rump length:
- Below 95th percentile: Approximately 97% of babies born healthy; genetic defect risk ~0.2%
- 95th to 99th percentile: 93% born healthy; genetic defect risk increases to ~3.7%
- 3.5–4.4 mm: Healthy outcome ~70%; genetic defect risk ~21%
- 4.5–5.4 mm: Healthy outcome ~50%; genetic defect risk ~33%
- ≥5.5 mm: Significantly elevated risk; further diagnostic testing strongly recommended
These figures emphasize that even moderately elevated NT does not indicate certain abnormality; many pregnancies with high NT values proceed to deliver unaffected babies. Conversely, a normal NT provides reassurance but does not guarantee a healthy outcome.